MedTrace Logo

Multiple Biomarkers in Undiagnosed Pleural Effusion

NCT00316134 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2011-11-08

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the ability of various biomarkers measured in serum and/or pleural fluids to estimate the risk of finding cancer in patients with undiagnosed pleural effusions. An algorithm for prediction of the risk of finding cancer in the patient using an optimal combination of markers will be developed, and patients will be categorized as having a low, moderate, or high risk of finding cancer that might be used to more effectively triage patients.

Conditions

  • Pleural Effusion
  • Pleural Effusion, Malignant

Interventions

PROCEDURE

Procedure/Surgery

Diagnostic and/or therapeutic procedure to remove pleural fluid.

Sponsors & Collaborators

  • Fujirebio Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Jeffrey Allard, PhD · Fujirebio Diagnostics, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00316134 on ClinicalTrials.gov